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Histone H3.3 is a replication-independent histone
variant, which replaces histones that are turned
over throughout the entire cell cycle. H3.3 deposition
at euchromatin is dependent on HIRA, whereas
ATRX/Daxx deposits H3.3 at pericentric heterochro-
matin and telomeres. The role of H3.3 at heterochro-
matic regions is unknown, but mutations in the
ATRX/Daxx/H3.3 pathway are linked to aberrant telo-
mere lengthening in certain cancers. In this study, we
show that ATRX-dependent deposition of H3.3 is not
limited to pericentric heterochromatin and telomeres
but also occurs at heterochromatic sites throughout
the genome. Notably, ATRX/H3.3 specifically local-
izes to silenced imprinted alleles in mouse ESCs.
ATRX KO cells failed to deposit H3.3 at these sites,
leading to loss of the H3K9me3 heterochromatin
modification, loss of repression, and aberrant allelic
expression. We propose a model whereby ATRX-
dependent deposition of H3.3 into heterochromatin
is normally required to maintain the memory of
silencing at imprinted loci.
INTRODUCTION
In mammalian cells, DNA is packaged into chromatin, which can
be differentially modified in association with different transcrip-
tional states. Modifications associated with transcribed euchro-
matin include histone acetylation, H3K4me3 at promoters, and
H3K36me3 within the gene body. The reversible gene silencing
at facultative heterochromatin is mediated by H3K27me3 and
thePolycombgroupproteins,while permanent silencingof repet-
itive constitutive heterochromatin is linked to DNA methylation,
H3K9me3, and H4K20me3. These epigenetic modifications are
thought to contribute to gene regulation and toprovide a template
for cellular identity, heritable through cell divisions.
As modified histones are displaced from DNA during replica-
tion, the maintenance of chromatin states is dependent on therapid reassembly of chromatin onto newly replicated DNA
(Jasencakova et al., 2010). The reassembled chromatin is
composed of a mixture of recycled, modified histones and naive
histones (Groth et al., 2007; Jackson, 1988) newly synthesized
during the S phase. The preservation of chromatin modifications
in daughter cells theoretically could be accomplished by chro-
matin modifiers recognizing specific marks on recycled histones
and imparting these same marks on adjacent newly synthesized
histones (Abmayr and Workman, 2012; Groth et al., 2007).
Histone displacement is not only linked to DNA replication but
also can occur spontaneously or during processes such as tran-
scription (Ahmad and Henikoff, 2002; Rando and Ahmad, 2007;
Schwartz and Ahmad, 2005) and DNA repair (reviewed in Soria
et al., 2012). However, as synthesis of canonical histones is
restricted to the S phase, replication-independent histone vari-
ants are used as replacements outside of the S phase. One
such example is the H3.3 histone variant that is expressed
throughout the cell cycle (Ahmad and Henikoff, 2002). The gen-
eral localization patterns of H3.3, around the promoters and
within the gene bodies of expressed genes, is consistent with
the idea that H3.3 is deposited as a replacement histone at tran-
scribed genes (Goldberg et al., 2010; Kraushaar et al., 2013;
Schwartz and Ahmad, 2005; Wirbelauer et al., 2005). Further-
more, a number of studies indicated that H3.3 is preferentially
marked by modifications associated with active euchromatin
and depleted of silencing modifications (Hake et al., 2006;
McKittrick et al., 2004), leading to the notion that H3.3 is predom-
inantly associated with transcription and is a marker for active
chromatin. However, H3.3 also has been detected at pericentric
heterochromatin (PCH) and telomeres, regions of silenced
constitutive heterochromatin, and the role of H3.3 at these sites
is currently unclear (Drane´ et al., 2010; Goldberg et al., 2010;
Wong et al., 2009, 2010).
Intriguingly, the deposition of H3.3 into these two distinctive
chromatin compartments appears to be dependent on two
separate pathways. Deposition of H3.3 at euchromatin and biva-
lent-chromatin promoters is mediated by HIRA, an H3.3-specific
histone chaperone (Banaszynski et al., 2013; Goldberg et al.,
2010; Ray-Gallet et al., 2002). Concordantly, HIRA shows strong
co-localization with H3.3 and active histone modifications
across the genome (Goldberg et al., 2010; Kraushaar et al.,Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authors 405
2013; Pchelintsev et al., 2013), and HIRA knockouts (KOs) fail to
deposit H3.3 at euchromatic sites in the genome, including pro-
moters, gene bodies, and enhancers (Goldberg et al., 2010;
Pchelintsev et al., 2013). In contrast, deposition of H3.3 at PCH
and telomeres is dependent on a second complex comprised
of Daxx and ATRX (Drane´ et al., 2010; Goldberg et al., 2010;
Wong et al., 2010). Both ATRX and Daxx are required for the
deposition of H3.3 at these repeats, and mutations in the
ATRX/Daxx/H3.3 pathway have been linked to certain cancers
and an alternative lengthening of telomeres (ALT) phenotype
(Heaphy et al., 2011; Jiao et al., 2011; Lovejoy et al., 2012;
Schwartzentruber et al., 2012), demonstrating the importance
of this pathway in maintaining chromatin integrity and, with it,
genomic stability.
In this study, we expanded on the role of the ATRX/Daxx com-
plex in H3.3 deposition across the genome. Here we show that
ATRX-dependent deposition of H3.3 is not limited to PCH and
telomeres, but also occurs at other distinct heterochromatic re-
gions dispersed throughout the genome, most notably at the
silenced alleles of imprinted genes. Using these imprinted genes
as amodel, we demonstrate that ATRX-dependent deposition of
H3.3 preferentially localizes to the DNA-methylated allele, indi-
cating that this process must be driven epigenetically. Finally,
we demonstrate that H3.3 deposition is crucial for the somatic
maintenance of H3K9me3 at many constitutive heterochromatic
regions, and we propose a role for this histone variant in main-
taining the epigenetic memory of silenced heterochromatin.
RESULTS
ATRX and H3.3 Are Enriched at Heterochromatic
Repeats throughout the Genome
Previously published data of validated ATRX chromatin immu-
noprecipitation sequencing (ChIP-seq) in mouse embryonic
stem cells (ESCs) were obtained from the GEO database
(GSM551138) (Law et al., 2010), and reads were aligned to
genomic repeats using Repeats Enrichment Estimator (Day
et al., 2010). Consistent with previous studies, ATRX was
enriched at pericentric and telomeric repeats relative to input
(Figure 1A; Goldberg et al., 2010; Law et al., 2010). In addition,
ATRX was enriched at a number of other genomic repeats (Fig-
ure S1). As genomic repeats are known to be enriched for
H3K9me3 and H4K20me3, chromatin modifications that are
associated with heterochromatin, all ATRX-binding sites across
the genome also were tested for association with these two
repressive modifications.
ChIP-seq reads for ATRX, H3K9me3 (GSM1375155) (Bulut-
Karslioglu et al., 2014), and H4K20me3 (GSM656527) were
aligned to the genome with Bowtie (Langmead, 2010), and
1,643 ATRX-binding sites were identified in mouse ESCs.
H3K9me3 and H4K20me3 ChIP-seq reads were quantitated un-
der ATRX peaks and compared to random genomic fragments
generated with RSA-tools (http://rsat.ulb.ac.be/rsat/random-
genome-fragments_form.cgi; Figure 1B). Both H3K9me3 and
H4K20me3 were enriched under ATRX-binding sites relative to
random control regions, indicating that ATRX is consistently
associated with these two heterochromatic modifications
throughout the genome. This is also consistent with a recent406 Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authorsstudy showing that the ATRX ADD domain is able to enrich
for H3K9me2/3- and H4K20me2/3-modified nucleosomes (Su
et al., 2014).
ATRX binding at pericentric and telomeric repeats has been
linked to the deposition of the histone variant H3.3 into these re-
gions (Drane´ et al., 2010; Goldberg et al., 2010; Wong et al.,
2010). Analysis of ChIP-seq results for histone H3.3 confirmed
that this histone variant was enriched at telomeric and PCH (Fig-
ure 1C, left). Given the strong relationship between ATRX and
H3.3 at repetitive heterochromatin, all ATRX-binding sites
throughout the genome were profiled for H3.3 enrichment.
Similar to the findings for H3K9me3 and H4K20me3, ATRX
genomic targets were generally enriched for H3.3 relative to
random genomic controls (Figure 1C, right). Intriguingly, ATRX-
binding sites were found to be simultaneously enriched for
the two histone marks of heterochromatin, H3K9me3 and
H4K20me3, as well as for H3.3 (Figure 1D).
We next looked for primary DNA sequence features that might
underlie ATRX-binding sites and found that ATRX primarily local-
izes to subsets of tandem repeats (n = 880) and endogenous
retroviral (ERVK) repeats (n = 247) in mouse ESCs. In addition,
ATRX was found to localize to CpG islands (CGIs) (n = 56) with
a higher frequency than expected by chance, though CGI targets
represent a relatively minor proportion of total ATRX peaks (Fig-
ures 1E and 1F). The majority of ATRX-binding sites in mouse
ESCs therefore can be classified as binding either tandem re-
peats, ERVK repeats, or CGIs, which are enriched for hetero-
chromatic modifications (H3K9me3/H4K20me3) and histone
H3.3 (Figure 1F, bottom; Figure S2).
ATRX Localizes to CGIs Associated with an Atypical
Chromatin Signature
ATRX-dependent deposition of histone H3.3 at telomeres and
PCH has been described previously and the co-localization of
H3K9me3 and H4K20me3 is consistent with the heterochromat-
ic nature of these regions. We have now extended this associa-
tion to other ATRX-binding sites, which, in the main, comprise
interstitial repeats that also appear to form segments of
heterochromatin.
In contrast, CGIs usually are associated with gene promoters,
transcription, and modifications associated with active chro-
matin, and the association with ATRX is unexplained. We there-
fore decided to examine chromatin modifications associated
with the identified ATRX-bound CGIs in more detail. Only 75
CGIs in the genome are overlapped by ATRX peaks, and in total
56 ATRX peaks that overlie CGIs were identified (some ATRX
peaks overlie more than one CGI). Typical of ATRX targets, but
unusual for CGIs, ATRX-bound CGIs were simultaneously en-
riched for H3K9me3, H4K20me3, and histone H3.3 (Figures 2A
and 2C). In addition, half of the ATRX-bound CGIs were DNA
methylated (GSE28254) (Brinkman et al., 2012), a modification
that is present at only 5% of CGIs genome wide (Figure 2B).
Sequential filters applied to CGIs across the genome isolated
several factors associated with ATRX binding. Selecting for CGIs
enriched for modifications associated with heterochromatin
(DNA methylation, H3K9me3, and H4K20me3) increased the
proportion of CGIs bound by ATRX (Figure 2D, left). Further se-
lection for CGIs associated with H3.3 enrichment and active
H3.3
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Figure 1. ATRX Localizes to Genomic Regions that Are Enriched for Heterochromatic (H3K9me3/H4K20me3)Modifications andHistone H3.3
(A) ATRX ChIP-seq reads are mapped to genomic repeats and normalized for total read count compared to input.
(B) (Left) H3K9me3 and (right) H4K20me3 are enriched under ATRX peaks compared to random genomic fragments. H3K9me3 and H4K20me3 ChIP-seq reads
were quantitated under ATRX peaks and normalized for total read counts. Normalized read counts under random genomic fragments were used as a control.
Boxes represent the 25th, median, and 75th percentiles; whiskers represent the 90th and 10th percentiles.
(C) (Left) H3.3 ChIP-seq reads are mapped to genomic repeats and normalized for total read count compared to input. (Right) H3.3 ChIP-seq quantitation under
ATRX peaks are normalized for total read count.
(D) Overlap between heterochromatic H3K9me3 and H4K20me3 marks and histone H3.3 under ATRX peaks. Enrichment is defined as normalized read
counts >75th percentile of random genomic fragments. Overlap of H3K9me3/H4K20me3/H3.3 enrichments in random fragments of the genome is shown as a
control.
(E) ATRX is enriched at tandem repeats (TRs), ERVK elements, and CGIs (CGI) in the genome relative to random genomic fragments.
(F) Proportion of ATRX-binding sites that overlie CGI, TRs, ERVK, and heterochromatin. See also Figure S1.transcription (determined by RNA sequencing [RNA-seq])
increased the ATRX-bound fraction to 90% (Figure 2D, left).
Assessment of ATRX peaks that overlapped CGIs showed that
28 of 56 (50%) of these ATRX peaks were not associated withpromoters (Table S1), compared to a genomic average of
23%. The majority (32 of 56) of ATRX-associated CGIs were
found to be localized to intragenic regions and embedded
within a transcriptional unit (Table S1; Figure 2E), and theyCell Reports 11, 405–418, April 21, 2015 ª2015 The Authors 407
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demonstrated a different profile of chromatin marks from those
seen at promoter CGIs (Figure 2E, top). The ATRX-binding sites
that overlapped CGI promoters showed minimal overlap be-
tween the peak of ATRX binding and the CGI, indicating these
overlaps may represent a distinct subclass (Figures S2D–S2F).
ATRX binding therefore is associated with a particular subset
of heterochromatin-modified intragenic CGIs, which also are en-
riched for H3.3 and transcribed.
Imprinted, Differentially Methylated Regions Are
Enriched for ATRX, Heterochromatic Modifications,
and H3.3
Filtering for features associated with ATRX-bound CGIs also led
to an enrichment for imprinted loci (Figure 2D, right; Table S1).
Imprinted genes are specialized genes that are expressed in a
monoallelic fashion, depending on the parental origin of the
allele. There are an estimated 150 imprinted genes in the mouse
genome, most of which are arranged in chromosomal clusters
(Williamson et al., 2014). The imprinted expression pattern of
multiple genes within a cluster can be controlled by single
imprinting control region (ICR). These specialized regions, which
commonly have the characteristics of CGIs, are marked by DNA
methylation on one of the two parental alleles. As this differential
DNAmethylation originates from one of the two germlines, these
regions are referred to as germline differentially methylated re-
gions (DMRs). Enrichment of ATRX was found at 12 of the 17
germline DMR regions that have been identified in the mouse
genome thus far (Table 1), and modest ATRX enrichment
(although not peak-called) was detected at an additional three
germline DMRs (Figure S3). In addition, ATRX binding was de-
tected at four imprinting-associated somatic DMRs, meaning
that ATRX peaks were seen at 16 of 21 (80%) of these highly
specialized regions of the genome (Table 1); 13 of these were
included in the list of ATRX-bound CGIs (Table S1). Interestingly,
the two DMRs that lacked any detectable enrichment of ATRX,
Gnas and Slc38a4, also were depleted of other factors
(H3K9me3, H4K20me3, and H3.3) associated with ATRX bind-
ing. ATRX enrichment at selected imprinted regions was further
confirmed by ChIP qPCR in wild-type (WT) versus ATRX KO
mouse ESCs (Figure S4A), and examples of these sites are
shown (Figure S4B).
ATRX localization at these regions coincided with enrichment
for heterochromatic modifications and histone H3.3 (Table 1;
Figure 3A, top). All ICRs and DMRs across the genome were
associated with DNA methylation, generally high levels of
H3K9me3 and H3.3, and mid-to-high levels of H4K20me3
(Table 1), the same chromatin signature linked to ATRX. ThisFigure 2. ATRX-Bound CGI Are Enriched for Marks of Heterochromati
(A) Normalized read counts of (left) H3K9me3, (middle) H4K20me3, and (right) H
represent the 25th, median, and 75th percentiles; whiskers represent the 90th and
(B) Proportion of CGI that are methylated genome-wide in comparison to ATRX-
(C) Overlapping enrichment profiles of H3K9me3, H4K20me3, and H3.3 under A
(D) (Left) Proportion of CGI that are bound by ATRX following sequential filtering
active transcription is shown. (Right) Proportion of CGI that are associated with
(E) Screenshots of the (top) Spred2 locus, (bottom left) Zfp629 locus, and (bottom
mid-level H3.3 compared to an ATRX-bound intragenic CGI, which is enriched wit
H3.3. See also Figure S2.means imprinted regions are linked with both ATRX binding
and its associated chromatin signature, implying a specialized
function for this particular combination of chromatin marks in
the genome.
ATRX and Histone H3.3 Preferentially Localize to the
Methylated Allele of Imprinted DMRs
Imprinted DMRs in the genome are characterized by differential
chromatin modifications, depending on the parental origin of the
allele (Fournier et al., 2002; Kelsey and Feil, 2013; Regha et al.,
2007; Singh et al., 2011). In general, one parental allele is modi-
fied with DNA methylation and histone modifications associated
with silenced heterochromatin, while the other allele is modi-
fied with marks of active chromatin, such as H3K4me3, associ-
ated with promoter activity on this parental allele. Screenshots
of selected imprinted DMRs in the mouse genome (Figure 3A,
top) illustrate some of the chromatin modifications that are
known to be associated with these regions. Importantly, as
ChIP-seq does not normally distinguish between alleles, the
active (H3K4me3) and heterochromatic (DNA methylation,
H3K9me3, and H4K20me3) modifications appear to overlap at
these regions, although these modifications are known to be
distributed allelically (Fournier et al., 2002; Pannetier et al.,
2008; Singh et al., 2011).
Given that ATRX, through its ADDdomain, is capable of recog-
nizing H3K9me3 (Dhayalan et al., 2011; Eustermann et al., 2011;
Iwase et al., 2011) while H3.3 is widely associated with active
chromatin, we wondered if these two proteins also might be
allelically distributed. This can be investigated using cells
derived from F1 offspring of parental mouse strains that harbor
distinctive SNPs, such as an inbred female SV129 crossed to
an outbredMusm. castaneusmale (SV1293Cast F1). Publically
available ChIP-seq of H3K4me3 (GSM307605) and H3.3
(GSM487542) in mouse ESCs derived from a SV129 3 Cast
cross were obtained and aligned to the mouse genome. Reads
that spanned an informative SNP at relevant imprinted DMRs
were extracted and assigned to either the maternal or paternal
allele. H3K4me3 reads primarily localized to the unmethylated
allele, as previously reported, but, unexpectedly, H3.3 reads
were consistently found to be biased toward the opposite,
DNA-methylated allele (Figure 3A, bottom).
This finding was further confirmed by performing ChIP against
ATRX, H3.3, H3K9me3, and the activating H3K4me3 modifica-
tions in mouse ESCs derived from a similar female SV129 3
Cast male cross. Resulting ChIP products were amplified with
primers designed around polymorphic SNPs, and PCR products
were digested with restriction enzymes specific for either then (H3K9me3/H4K20me3 and DNA Methylation) and H3.3
3.3 ChIP-seq at ATRX-bound CGI relative to genomic CGI are shown. Boxes
10th percentiles.
bound CGI is shown.
TRX CGI compared to genomic CGI are shown.
for DNA methylation, H3K9me3/H4K20me3 enrichment, H3.3 enrichment, and
imprinting and ATRX after sequential filtering is shown.
right) Zfp787 locus show a typical promoter CGI marked by high H3K4me3 and
h marks of heterochromatin (DNAmethylation, H3K9me3, and H4K20me3) and
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Table 1. Germline Somatic DMRs Associated with Genomic Imprinting Are Frequently Bound by ATRX
DMR Chr Start End Feature Description CpGi Methylated ATRX H3.3c Daxxc H3 K9me3c H4 K20me3c H3 K4me3c H3 K27me3c
Germline DMRs chr1 63246988 63247117 Zdbf2 maternal noa yes yes mid mid high low mid low
chr2 174119625 174123318 Nespas-Gnasxl maternal yes yes yes mid high high high low high
chr2 174152576 174154820 Gnas maternal yes yes no mid mid mid mid low high
chr6 4695857 4699483 Peg10 maternal yes yes midb high mid high high mid mid
chr6 30684007 30689966 Peg1 maternal yes yes yes high high high mid mid mid
chr7 6680055 6685400 Peg3 maternal yes yes yes high high high mid low mid
chr7 67148447 67150182 Snrpn maternal noa yes yes high mid high low mid low
chr7 149765988 149768095 H19 paternal noa yes yes mid mid high mid low mid
chr7 150479567 150482810 Lit1/Kcnq1ot1 maternal yes yes midb high high high high mid mid
chr9 89771586 89778464 Rasgrf1 paternal noa yes midb high mid mid low low high
chr10 12809849 12811804 Zac1 maternal yes yes yes high high high high mid high
chr11 11925463 11927100 Meg1/Grb10 maternal yes yes yes high mid high high low high
chr11 22871974 22872993 Commd1 maternal yes yes yes high high mid high mid low
chr12 110765047 110769203 IG-DMR paternal yes yes yes high high high high mid mid
chr15 96884878 96885292 Slc38a4 maternal noa no no mid mid mid mid mid mid
chr17 12934169 12935733 Igf2r/Airn maternal yes yes yes high mid high mid low high
chr18 13130435 13133135 Impact maternal yes yes yes high high high high high low
Somatic DMRs chr2 157385786 157386317 Nnat maternal yes yes yes high high high high low mid
chr6 58856717 58857141 Herc3 maternal yes yes yes high high high high low mid
chr7 135831483 135832096 Inpp5f maternal yes yes yes high high high high mid mid
chr15 72639967 72640553 Trappc9 maternal yes yes yes high high high high low mid
ATRX peaks were observed at 11 of 17 germline DMRs in the genome and showedmid-level enrichment at three more DMRs. ATRX also bound to five somatic DMRs in mouse ESCs. All regions
were marked by DNA methylation and associated with high levels of H3K9me3 and H3.3. See also Figure S3. Low, <25th percentile of genome CpGi; mid, >25th and <75th percentile of genome
CpGi; high >75th percentile of genome CpGi.
aManually defined CpGi based on GC content.
bLow-level ATRX enrichment missed in peak calls.
cCategorized based on normalized read count relative to genome CpGi.
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Figure 3. ATRX Localizes Specifically to Methylated DMR in Imprinted Regions along with Histone H3.3 and ATRX and H3.3 Both Localize
Specifically to the Methylated Allele
(A) (Top) Screenshots show overlapping chromatin modifications at imprinted DMRs. Imprinted DMRs are simultaneously enriched for H3K4me3-activating
marks and heterochromatic marks (DNAmethylation, H3K9me3, and H4K20me3). ATRX and H3.3 also are enriched at these regions. (Bottom) Allelic distribution
of H3.3 and H3K4me3 is shown. ChIP-seq reads of H3.3 and H3K4me3 in F1 Cast3 129 mouse ESCs with informative SNPs were assigned to either maternal or
paternal alleles.
(B) Allele specific localization of ATRX, H3K9me3, H3.3, and H3K4me3 at (top left) Peg13, (top right) Peg3, (bottom left)Nap1L5, and (bottom right) IG-DMR. ChIP
products were PCR amplified and digested with allele-specific restriction enzymes. Products were separated by agarose gel electrophoresis. See also Figure S4.maternal or paternal allele. A number of imprinted loci were
tested and digestion patterns were compared to input controls
(Figure 3B; Figures S4C–S4F). In agreement with previous
studies (Fournier et al., 2002; Singh et al., 2011), the heterochro-
matic H3K9me3 modification preferentially localized with the
reported DNA-methylated allele, while the active H3K4me3
modification localized to the opposite unmethylated allele.
As predicted, ATRX was found to co-localize with the
H3K9me3-modified methylated allele, and, intriguingly, H3.3
also was enriched on the DNA-methylated allele. Digestion pat-
terns of H3.3 ChIP PCR products were more similar to H3K9me3and ATRX than H3K4me3 patterns at all polymorphic imprinted
DMRs tested (Figure 3B; Figures S4C–S4F). Therefore, ATRX
and H3.3 both localize preferentially with the heterochromatic
H3K9me3, DNA-methylated allele at imprinted DMRs.
ATRX Is Required for H3.3 Deposition and H3K9me3 at
Imprinted DMRs in the Genome
Given that ATRX is necessary for the correct deposition of H3.3
at PCH and telomeres, we wondered if ATRX also might be
necessary for the deposition of H3.3 at imprinted loci. ChIP-
seq of H3.3 was performed in WT and ATRX KO mouse ESCs,Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authors 411
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Figure 4. ATRX Is Required for Correct Deposition of H3.3 and H3K9me3 at DMRs
(A) Normalized read counts of H3.3 ChIP-seq in WT versus ATRX KOmouse ESCs at various genomic regions. ATRX-bound imprinted DMRs are highly enriched
for H3.3 and enrichment is lost in the absence of ATRX. Boxes represent the 25th, median, and 75th percentiles; whiskers represent the 90th and 10th percentiles.
(B) Screenshots show the (left) Igf2r/Airn, (middle) Trappc9/Peg13, and (right) Nap1L5/Herc3 DMRs that are enriched for H3.3 in WT cells and lose H3.3 in ATRX
KO cells.
(C) Screenshot shows the Trappc9 promoter that retains H3.3 in ATRX KO cells.
(D) Screenshot of a genomic region (chr17:13,021,841-13,220,327) shows a number of promoters that are enriched for H3K4me3 and H3.3 in WT cells. H3.3
profiles are unchanged in the ATRX KO cells.
(E and F) Relative enrichment of (E) H3.3 and (F) H3K9me3 at DMRs inWT and ATRXKOmouse ESCs. ChIP products were amplified by qRT-PCR and enrichment
was calculated relative to GAPDH after normalizing for input. Results represent the mean and SD of three independent experiments. See also Figure S5.and ATRX-binding sites were assessed for H3.3 enrichment.
Consistent with previous reports, genomic CGIs, which generally
are associated with promoters, were found to be moderately
enriched for H3.3 compared to random genomic fragments (Fig-
ure 4A). However, ATRX-bound imprinted DMRs were found to
be strikingly enriched for H3.3 in WT cells, and enrichment was
lost in the absence of ATRX (Figure 4A). This profile of H3.3412 Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authorsenrichment in WT cells and subsequent depletion in ATRX KO
cells was not restricted to ATRX-associated imprinted DMRs,
but appeared to be a general feature associated with ATRX bind-
ing throughout the genome (Figures S5A–S5D).
Examples of the chromatin profiles of WT ESCs at a number of
imprinted DMRs and the loss of H3.3 in ATRX KO cells are shown
in Figure 4B. This unique chromatin profile is limited specifically
to imprinted DMRs, since the canonical promoter CGIs of im-
printed genes do not bind ATRX and are unaffected in ATRX
KO cells (Figure 4C). Furthermore, promoter-associated CGIs
in general, which are marked with H3K4me3 (Figure 4D), retain
comparable levels of H3.3 enrichment in ATRX KO cells (Figures
4A and 4D).
ChIP qPCR of H3.3 at a number of imprinted DMRs in WT and
ATRX KO cells was used to confirm the loss of H3.3 at these
sites in the absence of ATRX (Figure 4E). As these sites also
were enriched for H3K9me3 (Figure 4B) and ATRX is known to
be associated with this modification, we profiled H3K9me3 in
the presence and absence of ATRX. Unexpectedly, we found
that loss of ATRX also led to the loss of H3K9me3 at all
imprinted DMRs tested (Figure 4F). In addition, we profiled a
number of non-imprinted ATRX intragenic CGI targets and
found a similar situation where ATRX KO led to the loss of
both H3.3 and H3K9me3 enrichment at these sites (Figures
S5E and S5F). All non-imprinted CGIs profiled were DNA meth-
ylated and modified as heterochromatin and located within the
intragenic regions of transcribed genes. Furthermore, analysis
of DNA methylation at imprinted DMRs in mouse ESCs also
demonstrated an erosion of methylation at these sites in ATRX
KO cells (Figure S5G).
Taken together, these data suggest that ATRX-bound intra-
genic CGIs, including imprinted DMRs, have a unique require-
ment for ATRX-mediated deposition of H3.3 and that these
interactions are necessary for the maintenance of H3K9me3 at
these sites.
ATRX/H3.3/H3K9me3 Are Required for the Silencing of
Numerous Imprinted Genes
Imprinted genes are characterized by monoallelic expression in
a parent-of-origin-dependent manner, and imprinted expression
is thought to be dependent on chromatin modifications, particu-
larly DNA methylation, associated with the ICRs and DMRs
(Barlow, 2011; Weaver and Bartolomei, 2014). As H3K9me3 is
linked to DNA methylation and gene silencing, we sought to
determine if loss of ATRX and associated loss of H3.3 and
H3K9me3 at these sites would lead to aberrant parental expres-
sion of imprinted genes.
To assess this, female SV129 mice carrying a floxed allele
of the X chromosome-linked ATRX gene (Garrick et al.,
2006) were crossed with castaneus males to generate a male
(SV1293Cast) F1 ESC line, which would allow allelic discrimina-
tion. The SV1293 Cast ATRXFlox ESCs were transduced with an
adenoviral Cre-GFP cassette (AdCre) to generate ATRX KO
cells. An adenoviral GFP cassette (AdGFP) was used as a nega-
tive control. Cells were sorted for GFP expression and RNA was
extracted for sequencing. ATRX KO was confirmed by genotyp-
ing PCR (Figure S6A), real-time PCR for ATRX expression (Fig-
ure S6B), and RNA-seq data (Figure S6C). RNA was separated
into PolyA+ and PolyA fractions to capture both stable and
unstable transcripts, and both fractions were subjected to
strand-specific RNA-seq. Reads were aligned to the genome,
and reads spanning an informative SNP were extracted and
assigned to parental genomes using customized Perl scripts
(Table S4). Only genes with more than 50 informative SNP reads
were considered for analysis.A control dataset of 1,500 random genes were assessed for
parental skewing (Table S4), and the average parental skew
was found to be 50% in the PolyA+ fraction and 54% in the
PolyA fraction toward SV129. The 150 imprinted genes
(http://www.har.mrc.ac.uk/research/genomic_imprinting/) were
assessed for allelic skewing (Table S4). Within the PolyA frac-
tion, 11 genes showed >66% skewing toward the expected
parental allele and one gene was skewed >60% toward the ex-
pected parental allele (Figure 5A). Within the PolyA+ fraction, a
total of 12 genes showed >66% skewing toward the expected
parental allele, while an additional four genes were skewed
>60% toward the expected parental allele (Figure 5B).
Focusing on 18 non-redundant genes that demonstrated
allelic biases consistent with the literature, we examined their
parental read distribution in the ATRX KO (AdCre) dataset. Five
of 18 imprinted genes analyzed demonstrated >10% disruption
in allelic distribution patterns in ATRX KO cells (Figure 5A), with
particular disruptions occurring at the ATRX-bound methylated
allele (Figures S6D–S6G). These results were broadly reproduc-
ible across a second independent experiment (Figures S6H and
S6I), with themore stable PolyA+ fraction demonstrating a higher
degree of reproducibility.
One example of an imprinted locus is illustrated in Figure 5C.
At the Commd1/Zrsr1 locus, the Commd1 gene is expressed
from the maternal allele, and the Zrsr1 promoter, which is intra-
genic with respect to Commd1, is methylated on the SV129
maternal allele. Data from previous experiments indicate that
ATRX, H3.3, and H3K9me3 also are localized to the maternal
SV129 allele. On the reciprocal paternal allele, Commd1 is silent
and Zrsr1 is unmethylated and expressed. RNA-seq data
confirmed Zrsr1 is preferentially expressed from the Castaneus
paternal allele (Figure 5B), while the expression from the
maternal SV129 allele is suppressed. In ATRX KO cells, there is
a substantial increase in Zrsr1 reads originating from the
SV129 maternal allele compared to WT cells (Figure 5C). This
suggests that loss of ATRX leads to the loss of H3.3 and
H3K9me3 and results in the de-repression of the normally
silenced maternal SV129 Zrsr1 allele.
In total, five genes demonstrated >10% disruption in allelic
distributions across four imprinted loci; Commd1/Zrsr1, Nespas,
Sgce, and Trappc9 (Figures S6D–S6G). Where appropriate,
the reads for the overlapping gene partner also have been illus-
trated. This indicates that aberrant allelic expression is a general
feature associated with the loss of ATRX at these sites (Figures
S6D–S6G).
DISCUSSION
Histone H3.3 is a replication-independent histone variant
(Ahmad and Henikoff, 2002) that is indispensable in mammalian
development (Bush et al., 2013). Numerous studies have indi-
cated that H3.3 primarily is associated with transcription (Gold-
berg et al., 2010; Kraushaar et al., 2013; Schwartz and Ahmad,
2005; Wirbelauer et al., 2005) and is enriched for modifications
associated with euchromatin (Hake et al., 2006; McKittrick
et al., 2004). The deposition of H3.3 into these euchromatic re-
gions is dependent on the HIRA chaperone complex (Ray-Gallet
et al., 2002), and HIRA KO leads to the loss of H3.3 at these sitesCell Reports 11, 405–418, April 21, 2015 ª2015 The Authors 413
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Figure 5. Allelic Read Distribution at Imprinted Genes Is Disrupted in ATRX KO Cells
(A and B) RNA-seq of WT and ATRX KO ESCs show skewed distribution of reads at a number of imprinted genes in the (A) PolyA and (B) PolyA+ fractions in WT
cells. Genes where allelic distribution differed by >10% in ATRX KO compared to WT cells are indicated in red. Allelic distribution of reads across randomly
chosen genes in the genome are shown for comparison. Error bars represent SD of allelic skewing across the random dataset.
(C) (Left) A schematic representation of the Zrsr1/Commd1 imprinted locus shows allelic expression and methylation patterns. (Right) Normalized read counts
arise from the maternal SV129 Zrsr1 allele in WT and ATRX KO cells. See also Figure S6.(Goldberg et al., 2010; Pchelintsev et al., 2013). However, his-
tone H3.3 also is associated with a second chaperone complex,
ATRX/Daxx, which is required for the deposition of H3.3 into
PCH and telomeres, regions that are considered constitutive
heterochromatin (Drane´ et al., 2010; Goldberg et al., 2010;
Wong et al., 2010). In this study, we show that this association
is not limited to PCH and telomeres, but also applies to distinct
heterochromatic regions distributed throughout the genome
where the presence or absence of ATRX has important func-
tional consequences on gene silencing.
Genome-wide analysis of ATRX-binding sites showed that
these were enriched for both heterochromatic marks
(H3K9me3 and H4K20me3) and H3.3. Among these were short
tandem repeats and intragenic CGIs, which included many im-414 Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authorsprinted DMRs. Here we chose to focus on the CGI targets of
ATRX. In addition to enrichment for H3K9me3 and H4K20me3,
ATRX-bound CGI sequences were also more likely to be methyl-
ated than the genomic average. The overwhelming majority of
annotated CGIs in the genome localized to gene promoters
and were enriched for either H3K4me3 or H3K27me3 in a
manner that reflects gene expression. In contrast, ATRX-bound
CGIs tended to localize within gene bodies, and the atypical
chromatin profile observed at these sites likely could be attrib-
uted to this genomic position. However, as these heterochro-
matic CGIs lie within active genes, these regions are nonetheless
transcribed, and our data suggest that transcription per se is a
factor that positively selects for ATRX binding. As H3.3 is known
to act as a replacement histone (reviewed in Elsaesser et al.,
2010), this link to transcription and the associated nucleosomal
turnover could partially explain the presence of H3.3 within these
intragenic regions.
H3.3 is generally considered a mark of active chromatin, and,
consistent with this, we found co-localization of H3.3 with
H3K4me3-modified promoters within our dataset. The deposi-
tion of H3.3 into gene-rich regions is thought to be predominantly
dependent on HIRA (Pchelintsev et al., 2013; Ray-Gallet et al.,
2002) rather than the ATRX/Daxx complex, a finding that is
also generally consistent with our data. We found that H3.3
was moderately enriched at CGI promoters across the genome
and this enrichment was unaffected in ATRXKO cells, confirming
that H3.3 deposition at these regions was generally independent
of ATRX. However, the ATRX-bound CGIs identified in this
study represent distinct exceptions to this general pattern. At
these particular heterochromatin-modified regions, ATRX bind-
ing coincided with unusually high enrichment for H3.3 and
deposition of H3.3 failed to occur in the absence of ATRX. Inter-
estingly, the CGIs that were positive for all the features associ-
ated with ATRX binding also included a substantial number of
imprinted DMRs.
ATRX previously has been reported as being involved in
silencing at imprinted loci, but in these reports ATRX was
required for developmental silencing of the active allele in
post-natal brain (Kernohan et al., 2010, 2014). Quite separate
from this phenomenon, we showed here that, in mouse
ESCs, ATRX acts to maintain the differential expression of the
alleles at imprinted loci. We found that at the majority of
DMRs in mouse ESCs, the silenced alleles were enriched for
marks of constitutive heterochromatin, ATRX, and histone
H3.3. The imprinted DMRs represent a unique and functionally
distinct set of genomic targets. At these developmentally
essential regions, though the two parental alleles are geneti-
cally identical, they carry distinct combinations of chromatin
modifications (Kelsey and Feil, 2013; Regha et al., 2007; Singh
et al., 2011; reviewed in Weaver and Bartolomei, 2014). Thus,
imprinted DMRs represent an excellent in vivo model system
for assessing chromatin-driven ATRX binding. Allelic discrimi-
nation assays at these sites showed that both ATRX and
H3.3 were preferentially localized to the DNA-methylated/
H3K9me3-modified allele, rather than the H3K4me3-modified
allele, at many of the imprinted DMRs. This indicates that
epigenetic factors play an important role in targeting ATRX-
dependent deposition of H3.3 at imprinted loci in this cellular
context.
We previously noted that ATRX-bound CGIs were localized to
intragenic regions rather than promoters. However, at imprinted
DMRs, these features were not mutually exclusive. A number of
imprinted genes were arranged in overlapping transcription
pairs, whereby the promoter of one gene was intragenic with
respect to a second transcriptional unit. In fact, this pattern of
overlapping antisense-oriented transcription is thought to be
important for the establishment of imprinting at many loci (re-
viewed in Barlow, 2011). Using the Commd1/Zrsr1 locus as an
example, the maternally methylated DMR is intragenic with
respect to Commd1 transcription, but, on the unmethylated
paternal allele, the same CGI acts as a promoter for Zrsr1
expression. Therefore, it is likely that the heterochromatin isletat the maternal Commd1 intragenic CGI suppresses expression
of Zrsr1 from this allele. However, the process of transcription
through Commd1 is predicted to disrupt the heterochromatin-
modified nucleosomes at this intragenic CGI, and, in the
absence of active maintenance, could potentially lead to the
erosion of modifications at this site over time. Results from this
study indicate that ATRX-dependent deposition of H3.3 plays a
key role in maintaining the heterochromatic modifications at
these sites, as loss of ATRX leads to the loss of both H3.3 and
H3K9me3 at imprinted DMRs and results in aberrant allelic
expression of a number of imprinted genes. Although we
observed only modest changes in gene expression in our acute
KO model of ATRX, H3.3 KO has been shown to result in
changes in expression of imprinted genes (Banaszynski et al.,
2013; Bush et al., 2013). ATRX KO in SV129 3 Cast ESCs was
lethal and, therefore, it was not possible to assess these effects
in long-term culture or mouse models. Nonetheless, these data
identify ATRX as a regulator of genomic imprinting in this ESC
model.
The preferential localization of ATRX and H3.3 to the DNA-
methylated allele of many imprinted DMRs indicates that the
chromatin environment is an important factor in determining
whether ATRX is recruited for the deposition of H3.3. A similar
situation was observed at several non-imprinted CGIs located
at intragenic regions of actively transcribed genes. These
intragenic CGIs were also DNA methylated and marked as het-
erochromatin, and localization of ATRX to these sites further
supports the idea of chromatin-driven binding. Finally, we
showed a decrease in both H3.3 and H3K9me3 at these sites
in the absence of ATRX, which, in turn, led to aberrant allelic
expression. This finding may have broader implications for
ATRX-dependent deposition of H3.3 at other genomic sites,
such as telomeres, where loss of ATRX and H3.3 also may
lead to the loss of heterochromatic modifications.
We hypothesize that ATRX localizes to distinct heterochro-
matic regions when these sites are subjected to nucleosomal
disruptions and that ATRX/Daxx helps to facilitate the timely
deposition of H3.3. The presumption is that ATRX/Daxx then
leads to the recruitment of other factors, including histone
lysine methyltransferase(s) such as Eset/Setdb1/Kmt1e, which
controls the H3K9me3 at imprinted DMRs (Girardot et al.,
2014; Yuan et al., 2009) that can modify the newly deposited
replacement histones, thus ensuring the faithful somatic main-
tenance of silencing modifications (Figures 6A–6C). In the
absence of ATRX, H3.3 is no longer deposited at its target
loci. This is associated with the loss of H3K9me3, de-repres-
sion, and aberrant transcription of the genes involved (Fig-
ure 6D). The recruitment of ATRX to these sites is most likely
driven by the combinatorial interaction of ATRX with both
H3K9me3 and HP1 (Eustermann et al., 2011; Iwase et al.,
2011) and transcription. At the heterochromatic allele of im-
printed DMRs, the Eset-mediated H3K9me3 is recognized by
HP1g (Pannetier et al., 2008), and our recent studies suggest
Eset can interact with ATRX, at least in vitro (data not shown).
This would provide a reinforcing feedback loop in which the
ATRX-mediated incorporation of H3.3 and its ensuing methyl-
ation of lysine-9 facilitate the recruitment of ATRX to the hetero-
chromatic regions involved.Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authors 415
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Figure 6. ATRX-Mediated Deposition of H3.3 Maintains Hetero-
chromatic Profiles during Transcription
(A) Schematic depiction of a gene containing a gene body CGI. Heterochro-
matic modifications such as H3K9me3 silence the internal CGI to prevent
cryptic transcription.
(B) Progression of RNA Pol II during transcription disrupts heterochromatin-
modified nucleosomes at the internal CGI.
(C) ATRX/Daxx mediate deposition of replacement H3.3 at the heterochro-
matic CGI and facilitate maintenance of chromatin modifications at this site.
(D) Loss of ATRX leads to failure of H3.3 deposition, loss of chromatin modi-
fications, and aberrant transcription.EXPERIMENTAL PROCEDURES
GEO Datasets
A list of GEO datasets used in this study can be found in Table S5.
ChIP
ATRX and Daxx ChIP were performed as previously described (Law et al.,
2010). In brief, cells were fixed in PBS with 2 mM EGS (Pierce 26103) for
45 min at room temperature followed by 1% formaldehyde for 20 min. Chro-
matin was sonicated to <500 bp and lysates were immunoprecipitated with
10 mg ATRX H300 (Insight Biotechnology sc-15408), 10 mg Daxx M-112 (Santa
Cruz Biotechnology sc-7152), or rabbit IgG control (Dako X0903). Histone
ChIPs were performed according to the manufacturer’s instructions (Millipore
17-295) using either 10 mg H3.3 antibody (Millipore 09-838), 5 mg H3K9me3
antibody (Abcam ab8898), or 2 mg H3K4me3 antibody (Abcam ab8580).
ChIP-Seq Analysis
Fastq files were aligned to the mouse (mm9) genome with Bowtie (v1.0.0)
(Langmead, 2010) using default settings, except that reads were allowed to
match the genome up to five times to facilitate mapping to repeats. ATRX
peak calls were performed in Seqmonk (v0.24.1) (http://www.bioinformatics.
babraham.ac.uk/projects/seqmonk/), and reads associated with histone
modifications were quantitated under ATRX peaks after normalizing for total
mapped reads. Further details are provided in the Supplemental Experimental
Procedures.
Repeats Analysis
Fastq files were aligned to genomic repeats using Repeat Enrichment Esti-
mator v1.0. Mapped reads were normalized for total read count and compared
to input samples. Repeats with less than 50 mapped reads were excluded416 Cell Reports 11, 405–418, April 21, 2015 ª2015 The Authorsfrom further analysis. Repeat classes were considered enriched for protein
binding if ChIP-seq reads exceeded input reads by more than 2-fold after
normalizing for total read counts.
Identification of SNPs in ChIP-Seq Reads
ChIP-seq data of H3K4me3 (GSM307605) and H3.3 (GSM487542) in female
SV129 3 Castaneus male F1 ESCs were obtained from GEO. SNPs that
differed between these two strains were obtained from The Mouse Genomes
Project at the Wellcome Trust Sanger Institute webpage (https://www.sanger.
ac.uk/resources/mouse/genomes/). ChIP-seq reads were mapped using
Bowtie and reads that overlapped DMRs were extracted. As the IG-DMR
was significantly broader than the ATRX-binding site, only reads underlying
the ATRX peak were extracted from this region. DMR reads were overlapped
with SNPs and parental SNPs were identified using custom Perl scripts (avail-
able upon request).
Allelic Discrimination Assays
ATRX-bound DMRs were assessed for differential SNPs that created a differ-
ential restriction site. Primers were designed around appropriate sites and
used to amplify ChIP DNA. PCRs were performed using Expand High-Fidelity
Taq (Roche 11732641001) according to the manufacturers’ instructions. ChIP
or input DNA (1 ml) was amplified in a 50-ml reaction for 40 cycles with an
annealing temperature of 55C. Equal amounts of PCR products were sub-
jected to restriction digest and separated on a 2.5% agarose gel. Digestion
products were visualized using Sybr Gold (Life Technologies S-11494).
Digested PCR products were quantified in ImageJ and allelic enrichments
were calculated relative to input. A list of primers used in this study can be
found in Table S2.
Real-Time qPCR
Real-time qPCR was performed using SYBR green mastermix (Applied Bio-
systems 4309155). ChIP enrichments were determined relative to a three-point
dilution series of input DNA and normalized relative to GAPDH enrichment. A
list of primers used in this study can be found in Table S3.
Generation of SV129 3 Castaneus ATRX KO ESCs
SV129 females carrying an ATRXFlox cassette (Garrick et al., 2006) were mated
with Castaneus males and ESCs were derived from male ATRXFlox embryos.
An adenoviral-packaged Cre-recombinase cassette with a GFP marker
(Vector Laboratories 1779) (AdCre) was used to generate ATRX KO ESCs.
An adenoviral-packaged eGFP cassette (AdGFP) was used as a negative con-
trol (Vector Laboratories 1768). One million ESCs were seeded in a T25 flask
and transduced with 1 3 108 plaque-forming units (PFU) of either AdCre or
AdGFP adenovirus in 10 ml media. Transduced cells were recovered for
48 hr and then subjected to fluorescence-activated cell sorting (FACS) for
GFP expression. AdCre GFP-positive cells were confirmed as ATRX KO by
genotyping PCR and qPCR for ATRX expression. AdGFP-positive cells were
retained as a negative control.
RNA Extraction and Sequencing
RNA was extracted at 5 days post-transduction with Tri-Reagent (Sigma-
Aldrich T9424). Total RNA was separated using a PolyATtract mRNA Isolation
System (Promega Z5310). The rRNA was removed from PolyA fractions with
a Ribo-Zero Magnetic Kit (EpiCentre MRZH11124). Libraries were created
using NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New
England Biolabs E7420L) with minor modifications (Lamble et al., 2013),
and sequenced on a HiSeq2500 in rapid mode to generate 50 bp paired-
end reads.
Allelic RNA-Seq Analyses
RNA-seq data were aligned to the mm9 genome with TopHat v2.0.10 (Trapnell
et al., 2009) using default parameters. Parental SNPs across genes were iden-
tified as previously described for ChIP-seq datasets, except that reads were
analyzed in a strand-specific manner. RNA-seq reads also were extracted
from 1,500 random genes and used to assess the distribution of parental
SNPs. Only genes with more than 50 informative SNP reads were included
in the analysis.
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deposited to the NCBI GEO and are available under accession number
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